Literature DB >> 1442065

[Effects of astragalus (ASI, SK) on experimental liver injury].

Y D Zhang1, J P Shen, S H Zhu, D K Huang, Y Ding, X L Zhang.   

Abstract

The saponins (ASI, SK) used in this study was extracted from the root of Astragalus membranaceous Bge and Astragalus sieversianus Pull. ASI and SK were found to protect liver from chemical injury induced by CCl4, D-galactosamine and acetaminophen in mice. The two saponins were shown to impede the elevation of SGPT level, decrease the MDA content and increase the GSH concentration in mouse liver. Obvious improvement of histological changes were also observed. The protective action of ASI and SK against the hepatotoxicity was also shown in experiments using primary cultured rat hepatocytes. The average value of GPT in the medium treated with different concentration of ASI and SK (0.00075-0.18 mmol/L) was lower than that in control. Analyzing through multiple linear correlation, we showed that the lowering of SGPT was negatively related to the increase of GSH, positively related to the decrease of MDA in mice given CCl4 or acetaminophen in combination with ASI or SK. These results indicate that the hepato-protective effects of ASI and SK may be due to their anti-oxidation activities, since the content of liver protein in mice given ASI or SK was more than that in the controls. Moreover, the level of hepatic microsomal cytochrome P-450 in all mice given the two saponins were significantly increased, the liver metabolism and immunoregulating action produced by ASI and SK may be also involved in their hepato-protective effects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1442065

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  5 in total

1.  Absorption enhancement study of astragaloside IV based on its transport mechanism in caco-2 cells.

Authors:  C R Huang; G J Wang; X L Wu; H Li; H T Xie; H Lv; J G Sun
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jan-Mar       Impact factor: 2.441

2.  Protective effect of fufanghuangqiduogan against acute liver injury in mice.

Authors:  Shuang-Ying Gui; Wei Wei; Hua Wang; Li Wu; Wu-Yi Sun; Cheng-Yi Wu
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

3.  Preventive effect of Qianggan-Rongxian Decoction on rat liver fibrosis.

Authors:  Chun-Hui Li; Li-Hui Pan; Zong-Wei Yang; Chun-Yu Li; Wen-Xie Xu
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

4.  Inhibitory effect of Huangqi Zhechong decoction on liver fibrosis in rat.

Authors:  Shuang-Suo Dang; Xiao-Li Jia; Yan-An Cheng; Yun-Ru Chen; En-Qi Liu; Zong-Fang Li
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

5.  Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism.

Authors:  Huan Zhang; Jiaying Song; Huizhen Dai; Yanchao Liu; Lili Wang
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.